Eli Lilly has announced plans to expand the tirzepatide launch across Mexico, along with other markets including China, India, and Brazil
The parallel REDEFINE 2 study evaluated the cagrilintide + semaglutide combination in adults with type 2 diabetes, documenting a significant body-weight reduction and improved glycemic control
S em junho vieram os primeiros dados robustos: um estudo publicado na revista The Lancet mostrou perda mdia de 28,3% do peso corporal entre pacientes com diabetes tipo 2 que receberam a dose mais alta
Glucagon-like peptide-1 receptor agonists: What ophthalmologists need to know
While its usually not a cause for serious concern, a reaction on your face could indicate that your body is reacting to the medication in an unexpected or undesirable way
Furthermore, anakinra, an IL-1 inhibitor that significantly improved respiratory function in patients with severe COVID-19 (ref